Cargando…
Fungal-Induced Programmed Cell Death
Fungal infections are a cause of morbidity in humans, and despite the availability of a range of antifungal treatments, the mortality rate remains unacceptably high. Although our knowledge of the interactions between pathogenic fungi and the host continues to grow, further research is still required...
Autores principales: | Williams, Thomas J., Gonzales-Huerta, Luis E., Armstrong-James, Darius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003624/ https://www.ncbi.nlm.nih.gov/pubmed/33804601 http://dx.doi.org/10.3390/jof7030231 |
Ejemplares similares
-
Future Directions for Clinical Respiratory Fungal Research
por: Armstrong-James, Darius
Publicado: (2021) -
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
por: Jaafar, Jaafar, et al.
Publicado: (2018) -
PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
por: Murray, Alison, et al.
Publicado: (2020) -
Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin
por: Jang, Jung Yoon, et al.
Publicado: (2022) -
Programmed Cell Death in Cystinosis
por: Ames, Elizabeth G., et al.
Publicado: (2022)